Direct effects of TGFβ on cancer cells’ chemoresistance are mediated by the TGF-β/SMAD pathway and miRNAs targeting components of the TGF-β pathway (SMAD2, SMAD3, SMAD4). The gene discussed is SMAD2; the disease is cancer.